Literature DB >> 8403249

Transforming growth factor-beta in cardiac ontogeny and adaptation.

W R MacLellan1, T Brand, M D Schneider.   

Abstract

The transforming growth factor-beta (TGF-beta) superfamily comprises a set of regulatory peptides with multiple effects on cell growth and differentiation. The elaborate regulation of TGF-beta s during embryonic development of the heart, the upregulation of TGF-beta after hemodynamic stress, and the impact of TGF-beta on cardiac gene expression together imply a prominent functional role for this family of growth factors in cardiac organogenesis and hypertrophy. Basal and TGF-beta-induced expression of skeletal alpha-actin, one of several genes specifically associated with developing or hypertrophied myocardium, each are contingent on transcriptional activation by serum response factor. A truncated form of the type II TGF-beta receptor, created by deletion of the cytoplasmic kinase domain, acts as a dominant suppressor of TGF-beta signal transduction in cultured cardiac muscle cells and may provide a suitable means to establish the functions of TGF-beta in vivo.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8403249     DOI: 10.1161/01.res.73.5.783

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  24 in total

1.  Electrical stimulation of neonatal cardiomyocytes results in the sequential activation of nuclear genes governing mitochondrial proliferation and differentiation.

Authors:  Y Xia; L M Buja; R C Scarpulla; J B McMillin
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

2.  Overexpression of angiotensin II type I receptor in cardiomyocytes induces cardiac hypertrophy and remodeling.

Authors:  P Paradis; N Dali-Youcef; F W Paradis; G Thibault; M Nemer
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

3.  Stretch-induced VEGF expression in the heart.

Authors:  J Li; T Hampton; J P Morgan; M Simons
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

4.  Mitochondrial quality-control dysregulation in conditional HO-1-/- mice.

Authors:  Hagir B Suliman; Jeffrey E Keenan; Claude A Piantadosi
Journal:  JCI Insight       Date:  2017-02-09

5.  TGF-beta1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II.

Authors:  Jo El J Schultz; Sandra A Witt; Betty J Glascock; Michelle L Nieman; Peter J Reiser; Stacey L Nix; Thomas R Kimball; Thomas Doetschman
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

6.  Direct regulation of membrane type 1 matrix metalloproteinase following myocardial infarction causes changes in survival, cardiac function, and remodeling.

Authors:  Juozas A Zavadzkas; Rupak Mukherjee; William T Rivers; Risha K Patel; Evan C Meyer; Laurel E Black; Richard A McKinney; J Marshall Oelsen; Robert E Stroud; Francis G Spinale
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-06-10       Impact factor: 4.733

Review 7.  Molecular approaches to cardiac development and hypertrophy.

Authors:  M D Schneider; W R MacLellan; L A Kirshenbaum; T Brand
Journal:  Tex Heart Inst J       Date:  1994

8.  Progenitor cell therapy in a porcine acute myocardial infarction model induces cardiac hypertrophy, mediated by paracrine secretion of cardiotrophic factors including TGFbeta1.

Authors:  Brendan Doyle; Paul Sorajja; Brian Hynes; Arun H S Kumar; Phillip A Araoz; Paul G Stalboerger; Dylan Miller; Cynthia Reed; Jeffrey Schmeckpeper; Shaohua Wang; Chunsheng Liu; Andre Terzic; David Kruger; Stephen Riederer; Noel M Caplice
Journal:  Stem Cells Dev       Date:  2008-10       Impact factor: 3.272

Review 9.  Intramyocardial fibroblast myocyte communication.

Authors:  Rahul Kakkar; Richard T Lee
Journal:  Circ Res       Date:  2010-01-08       Impact factor: 17.367

10.  The genotype and expression of the TGFβ2 gene in children with congenital conotruncal defects.

Authors:  Yingying Meng; Xiaojing Ma; Jing Zhang; Huijun Wang; Duan Ma; Guoying Huang
Journal:  Pediatr Cardiol       Date:  2013-05-28       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.